Growth stocks are often shares of companies in rapidly evolving and innovative sectors, such as technology, artificial intelligence (AI), biotechnology, cannabis, or clean energy, which have the potential to disrupt existing industries or create entirely new markets. These stocks can benefit investors by offering the opportunity for capital appreciation as the underlying business grows.
Investors who focus on growth stocks often aim to build long-term wealth by holding onto shares for years, or even decades. Here we have two such biotech stocks, Alto Neuroscience (ANRO) and Trevi Therapeutics (TRVI), which are still in their early stages. Wall Street analysts believe these stocks have the potential to increase by more than 200% if they meet their high price estimates. Let's find out how.
